ubenimex has been researched along with Lymphoma, Non-Hodgkin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathe, G | 1 |
Bierman, PJ; Heimann, DG; Ino, K; Kuszynski, CA; Talmadge, JE; Varney, ML; Walker, SA | 1 |
Bruley-Rosset, M; Florentin, I; Kiger, N; Mathé, G; Schulz, J | 1 |
Blazsek, I; Canon, C; Gil-Delgado, M; Mathé, G; Misset, JL | 1 |
1 review(s) available for ubenimex and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
2 trial(s) available for ubenimex and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Biopterins; Bone Marrow Transplantation; Colony-Stimulating Factors; Combined Modality Therapy; Female; HLA-DR Antigens; Humans; Leucine; Lymphoma, Non-Hodgkin; Macrophage Activation; Macrophages; Male; Middle Aged; Monocytes; Neopterin; Receptors, IgG | 1996 |
From experimental to clinical attempts in immunorestoration with bestatin and zinc.
Topics: Adjuvants, Immunologic; Age Factors; AIDS-Related Complex; Animals; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leucine; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Mice; Neoplasms; T-Lymphocytes; Zinc | 1986 |
1 other study(ies) available for ubenimex and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
Topics: Aging; Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Hypersensitivity, Delayed; Immunity; Leucine; Life Expectancy; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Macrophages; Mice; Spleen; T-Lymphocytes, Regulatory | 1979 |